" class="no-js "lang="en-US"> Jonathan Yifat - Medtech Alert
Friday, January 17, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Jonathan Yifat

Jonathan Yifat

About Jonathan Yifat

Mr. Yifat has been leading Radiaction since its inception, from concept to product, through regulation and quality, to fund raising and business development. With over 12 years of experience in R&D management, Jonathan has a unique mix of hands on experience and strategic overview.

 

Prior to Radiaction, Jonathan was director of R&D team in the Ballistic Missile Defense field at WALES Ltd, heading cutting edge studies for Departments of Defense of various countries.

Jonathan received his BSc in Physics and Business Administration and MSc in Bio- Medical Engineering, all with honors, from Tel Aviv University.
Mr. Yifat was a regular keynote speaker at professional conferences around the world and published several papers and patents both in missile defense, and medical technologies

Related Story

Cardiovascular

 Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization | Pharmtech Focus

Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization

April 1 2022

Radiaction Medical Ltd. (“Radiaction”), an innovative medical device company focused on radiation protection in the interventional […]